Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC

Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC

Abstract Background Immune-checkpoint inhibitors (ICIs) have showed unprecedent efficacy in the treatment of patients with advanced non-small cell lung cancer (NSCLC). However, not all patients manifest clinical benefit due to the lack of reliable predictive biomarkers. We showed preliminary data on...

Full description

Bibliographic Details
Main Authors:	Diego de Miguel‑Perez, Murat Ak, Priyadarshini Mamindla, Alessandro Russo, Serafettin Zenkin, Nursima Ak, Vishal Peddagangireddy, Luis Lara‑Mejia, Muthukumar Gunasekaran, Andres F. Cardona, Aung Naing, Fred R. Hirsch, Oscar Arrieta, Rivka R. Colen, Christian Rolfo
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	Non-small cell lung cancer Immune-checkpoint inhibitors Liquid biopsy Biomarker Extracellular vesicle PD-L1 Radiomics
Online Access:	https://doi.org/10.1186/s13046-024-02997-x

Similar Items

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma
by: Riyue Bao, et al.
Published: (2025-02-01)

Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis
by: Wendi Kang, et al.
Published: (2023-09-01)

Radiogenomics and radiomics of Skull Base Chordoma: machine learning-based classification of genetic signatures and clinical outcomes by multiparametric MRI
by: Z.C. Gersey, et al.
Published: (2022-01-01)

Author Correction: A general skull stripping of multiparametric brain MRIs using 3D convolutional neural network
by: Linmin Pei, et al.
Published: (2022-07-01)

A Computed Tomography-Derived Radiomics Approach for Predicting Uncommon EGFR Mutation in Patients With NSCLC
by: Wufei Chen, et al.
Published: (2021-12-01)

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
by: Diego de Miguel-Perez, et al.
Published: (2022-06-01)

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
by: Qiuyuan Hu, et al.
Published: (2023-03-01)

MRI-Based Radiomics in Bladder Cancer: A Systematic Review and Radiomics Quality Score Assessment
by: Bianca Boca, et al.
Published: (2023-07-01)

CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency
by: Chandra Bortolotto, et al.
Published: (2024-06-01)

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features
by: Peng Hao, et al.
Published: (2024-11-01)

MRI radiomics and potential applications to glioblastoma
by: Grayson W. Hooper, et al.
Published: (2023-02-01)

Simplifying Radiomics Workflow for Predicting Grade of Glioma: An Approach for Rapid and Reproducible Radiomics
by: Yunus Soleymani, et al.
Published: (2025-02-01)

Radiomics Analysis for Multiple Myeloma: A Systematic Review with Radiomics Quality Scoring
by: Michail E. Klontzas, et al.
Published: (2023-06-01)

Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics
by: Kedar A. Patwardhan, et al.
Published: (2024-06-01)

Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach
by: Bihong T. Chen, et al.
Published: (2020-04-01)

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
by: Weicheng Huang, et al.
Published: (2022-04-01)

The Role of Radiomics in Salivary Gland Imaging: A Systematic Review and Radiomics Quality Assessment
by: Giacomo Aringhieri, et al.
Published: (2022-12-01)

Advancing Pediatric Sarcomas through Radiomics: A Systematic Review and Prospective Assessment Using Radiomics Quality Score (RQS) and Methodological Radiomics Score (METRICS)
by: Gayane Aghakhanyan, et al.
Published: (2024-04-01)

23 Validation of PD-L1 dynamic expression on extracellular vesicles as a predictor of response to immune-checkpoint inhibitors and survival in non-small cell lung cancer patients
by: Alessandro Russo, et al.
Published: (2021-11-01)

Utility of CT Radiomics and Delta Radiomics for Survival Evaluation in Locally Advanced Nasopharyngeal Carcinoma with Concurrent Chemoradiotherapy
by: Yen-Cho Huang, et al.
Published: (2024-04-01)

Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis
by: Wenzheng Sun, et al.
Published: (2018-10-01)

Delta-radiomics in cancer immunotherapy response prediction: A systematic review
by: Engy Abbas, et al.
Published: (2023-12-01)

Delta Radiomics Improves Pulmonary Nodule Malignancy Prediction in Lung Cancer Screening
by: Saeed S. Alahmari, et al.
Published: (2018-01-01)

Decoding Radiomics: A Step-by-Step Guide to Machine Learning Workflow in Hand-Crafted and Deep Learning Radiomics Studies
by: Maurizio Cè, et al.
Published: (2024-11-01)

Radiomics Feature Activation Maps as a New Tool for Signature Interpretability
by: Diem Vuong, et al.
Published: (2020-12-01)

Priority radiomic parameters for computed tomography of head and neck malignancies: A systematic review
by: Yuriy A. Vasilev, et al.
Published: (2024-09-01)

What does radiomics do in PD‐L1 blockade therapy of NSCLC patients?
by: Ruichen Cui, et al.
Published: (2022-10-01)

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
by: Amine Bouhamama, et al.
Published: (2023-05-01)

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer
by: Seung Hyuck Jeon, et al.
Published: (2019-03-01)

Advancing NSCLC pathological subtype prediction with interpretable machine learning: a comprehensive radiomics-based approach
by: Bingling Kuang, et al.
Published: (2024-05-01)

Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging
by: Xue Sha, et al.
Published: (2020-02-01)

Establishment and Optimization of Radiomics Algorithms for Prediction of KRAS Gene Mutation by Integration of NSCLC Gene Mutation Mutual Exclusion Information
by: Jingyi Wang, et al.
Published: (2022-04-01)

Radiomics and imaging genomics in precision medicine
by: Geewon Lee, et al.
Published: (2017-03-01)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
by: Satheesh Krishna, et al.
Published: (2023-08-01)

The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach
by: Jie Min, et al.
Published: (2024-09-01)

CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy
by: Liqiao Hou, et al.
Published: (2024-09-01)

Advances in research of radiomics and metabolomics in acute pancreatitis
by: ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
Published: (2024-08-01)

Radiomics in colorectal cancer
by: Long Wu, et al.
Published: (2023-09-01)

Effect of Blurring of Images on Their First Order Radiomic Features
by: Tumakov Dmitrii, et al.
Published: (2023-01-01)

Radiomics integration into a picture archiving and communication system
by: Ivan Zhovannik, et al.
Published: (2021-10-01)